Literature DB >> 15557261

A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.

Marian Seto1, Marc Whitlow, Margaret A McCarrick, Subha Srinivasan, Ying Zhu, Rene Pagila, Robert Mintzer, David Light, Anthony Johns, Janet A Meurer-Ogden.   

Abstract

Sequence profile and fold recognition methods identified mammalian purple acid phosphatase (PAP), a member of a dimetal-containing phosphoesterase (DMP) family, as a remote homolog of human acid sphingomyelinase (ASM). A model of the phosphoesterase domain of ASM was built based on its predicted secondary structure and the metal-coordinating residues of PAP. Due to the low sequence identity between ASM and PAP (approximately 15%), the highest degree of confidence in the model resides in the metal-binding motifs. The ASM model predicts residues Asp 206, Asp 278, Asn 318, His 425, and His 457 to be dimetal coordinating. A putative orientation for the phosphorylcholine head group of the ASM substrate, sphingomyelin (SM), was made based on the predicted catalysis of the phosphorus-oxygen bond in the active site of ASM and on a structural comparison of the PAP-phosphate complex to the C-reactive protein-phosphorylcholine complex. These complexes revealed similar spatial interactions between the metal-coordinating residues, the metals, and the phosphate groups, suggesting a putative orientation for the head group in ASM consistent with the mechanism considerations. A conserved sequence motif in ASM, NX3CX3N, was identified (Asn 381 to Asn 389) and is predicted to interact with the choline amine moiety in SM. The resulting ASM model suggests that the enzyme uses an SN2-type catalytic mechanism to hydrolyze SM, similar to other DMPs. His 319 in ASM is predicted to protonate the ceramide-leaving group in the catalysis of SM. The putative functional roles of several ASM Niemann-Pick missense mutations, located in the predicted phosphoesterase domain, are discussed in context to the model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557261      PMCID: PMC2287300          DOI: 10.1110/ps.04966204

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  69 in total

1.  Acid sphingomyelinase from human urine: purification and characterization.

Authors:  L E Quintern; G Weitz; H Nehrkorn; J M Tager; A W Schram; K Sandhoff
Journal:  Biochim Biophys Acta       Date:  1987-12-14

2.  An enzyme with a double identity: purple acid phosphatase and tartrate-resistant acid phosphatase.

Authors:  J B Vincent; B A Averill
Journal:  FASEB J       Date:  1990-09       Impact factor: 5.191

3.  Rapid and sensitive sequence comparison with FASTP and FASTA.

Authors:  W R Pearson
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  The SWISS-PROT protein sequence data bank: current status.

Authors:  A Bairoch; B Boeckmann
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

5.  Conserved sequence pattern in a wide variety of phosphoesterases.

Authors:  E V Koonin
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

Review 6.  Sphingomyelinases and Niemann-Pick disease.

Authors:  T Levade; R Salvayre; L Douste-Blazy
Journal:  J Clin Chem Clin Biochem       Date:  1986-04

7.  A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate.

Authors:  W Sperl; G Bart; M T Vanier; H Christomanou; I Baldissera; E Steichen-Gersdorf; E Paschke
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Mutational analysis of a Ser/Thr phosphatase. Identification of residues important in phosphoesterase substrate binding and catalysis.

Authors:  S Zhuo; J C Clemens; R L Stone; J E Dixon
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

9.  The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups.

Authors:  J W Callahan; C S Jones; D J Davidson; P Shankaran
Journal:  J Neurosci Res       Date:  1983       Impact factor: 4.164

10.  Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.

Authors:  C P Ponting
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

View more
  9 in total

1.  Structure and biological activities of beta toxin from Staphylococcus aureus.

Authors:  Medora Huseby; Ke Shi; C Kent Brown; Jeff Digre; Fikre Mengistu; Keun Seok Seo; Gregory A Bohach; Patrick M Schlievert; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

2.  Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann-Pick disease type B.

Authors:  Mariana Acuña; Pablo Martínez; Carol Moraga; Xingxuan He; Mauricio Moraga; Bessie Hunter; Peter Nuernberg; Rodrigo A Gutiérrez; Mauricio González; Edward H Schuchman; José Luis Santos; Juan Francisco Miquel; Paulina Mabe; Silvana Zanlungo
Journal:  Eur J Hum Genet       Date:  2015-04-29       Impact factor: 4.246

3.  Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.

Authors:  Russell W Jenkins; Daniel Canals; Jolanta Idkowiak-Baldys; Fabio Simbari; Patrick Roddy; David M Perry; Kazuyuki Kitatani; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

4.  Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.

Authors:  Iwan Jones; Xingxuan He; Fourogh Katouzian; Peter I Darroch; Edward H Schuchman
Journal:  Mol Genet Metab       Date:  2008-09-23       Impact factor: 4.797

5.  Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages.

Authors:  Mathew Traini; Carmel M Quinn; Cecilia Sandoval; Erik Johansson; Kate Schroder; Maaike Kockx; Peter J Meikle; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

6.  Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.

Authors:  Yan-Feng Zhou; Matthew C Metcalf; Scott C Garman; Tim Edmunds; Huawei Qiu; Ronnie R Wei
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

7.  Plasma membrane damage repair is mediated by an acid sphingomyelinase in Entamoeba histolytica.

Authors:  Fátima Ramírez-Montiel; Claudia Mendoza-Macías; Sairy Andrade-Guillén; Ángeles Rangel-Serrano; Itzel Páramo-Pérez; Paris E Rivera-Cuéllar; B Liliana España-Sánchez; Gabriel Luna-Bárcenas; Fernando Anaya-Velázquez; Bernardo Franco; Felipe Padilla-Vaca
Journal:  PLoS Pathog       Date:  2019-08-28       Impact factor: 6.823

Review 8.  Niemann-Pick disease, type B with TRAP-positive storage cells and secondary sea blue histiocytosis.

Authors:  P Sharma; R Kar; S Dutta; H P Pati; R Saxena
Journal:  Eur J Histochem       Date:  2009-09-30       Impact factor: 3.188

9.  The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity.

Authors:  Leonhard X Heinz; Christoph L Baumann; Marielle S Köberlin; Berend Snijder; Riem Gawish; Guanghou Shui; Omar Sharif; Irene M Aspalter; André C Müller; Richard K Kandasamy; Florian P Breitwieser; Andreas Pichlmair; Manuela Bruckner; Manuele Rebsamen; Stephan Blüml; Thomas Karonitsch; Astrid Fauster; Jacques Colinge; Keiryn L Bennett; Sylvia Knapp; Markus R Wenk; Giulio Superti-Furga
Journal:  Cell Rep       Date:  2015-06-18       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.